The inhibition of osteosarcoma growth following SENP5-knockdown is likely via an increase in caspase-3/-7 activity (apoptosis activators) and a decrease in the expression of the cell cycle gene, cyclin B1 [146] (Figure 3D). The gene discussed is SENP5; the disease is osteosarcoma.